Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 127 clinical trials
Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions

risk of bleeding in predisposed patients (von Willebrand factor deficiency, antiplatelet therapy). The objective of the study is to evaluate the performance of this new hemostasis test in whole

antiplatelet therapy
von willebrand factor
haemostasis
clot
deficiency
  • 19 views
  • 25 Jan, 2021
  • 3 locations
Risk Stratification Post TAVI Using TEG

strategy post TAVI is still unclear. Current European guidelines recommend dual antiplatelet therapy (DAPT) for 3 to 6 months.The prevalence of subclinical leaflet thrombosis after TAVI is 15% up to 40

  • 0 views
  • 26 Jan, 2021
  • 1 location
Application of the "Haemoblock" in Pacemaker Patients

pocket is of great practical interest. This question is especially acute in relation to patients who are constantly on anticoagulation and/or antiplatelet therapy. A number of authors propose to carry

  • 0 views
  • 09 Mar, 2021
  • 1 location
Association Between the Composition of the Bacterial Flora of Thrombi and the Etiological Origin of Cerebral Infarction Treated With Thrombectomy

factors. If the cause is atrial fibrillation, the treatment of choice is anticoagulation therapy. Cryptogenic strokes are managed with antiplatelet therapy. In past studies, the thrombi responsible for

  • 0 views
  • 25 Jan, 2021
  • 1 location
Combining Left Atrial Appendage Closure With Cryoballoon Ablation in Chinese Population

Cryoablation combined with left atrial appendage closure is a novel strategy for atrial fibrillation patients. Through long-term follow-up, the investigators aimed to observe the safety and efficacy of the combined procedure in Chinese population.

anticoagulants
vascular disease
left atrial appendage closure
  • 0 views
  • 27 Jan, 2021
  • 1 location
Atrial Fibrillation After CABG and PCI

Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice and is associated with an increased risk of stroke, heart failure and death. Oral anticoagulation (OAC) is the only treatment so far being able to reduce mortality in AF patients, despite new antiarrhythmic drugs and ablation techniques. Postoperative …

infarct
atrial fibrillation
ischemic stroke
  • 0 views
  • 21 Mar, 2021
  • 2 locations
Analysis of the Microbiota and STEMI

Hyperglycemia is a common finding in patients diagnosed with acute coronary syndrome (ACS), and an independent predictor of mortality in patients with and without diabetes. Though percutaneous coronary intervention (PCI) is the cornerstone of ST-segment elevation myocardial infarction (STEMI), the incidence of heart failure, re-infarction and death in hyperglycemic patients …

percutaneous coronary intervention
hyperglycemia
  • 0 views
  • 26 Jan, 2021
  • 1 location